1. Home
  2. RCKT vs OIS Comparison

RCKT vs OIS Comparison

Compare RCKT & OIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • OIS
  • Stock Information
  • Founded
  • RCKT 1999
  • OIS 1995
  • Country
  • RCKT United States
  • OIS United States
  • Employees
  • RCKT N/A
  • OIS N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • OIS Metal Fabrications
  • Sector
  • RCKT Health Care
  • OIS Industrials
  • Exchange
  • RCKT Nasdaq
  • OIS Nasdaq
  • Market Cap
  • RCKT 328.6M
  • OIS 333.9M
  • IPO Year
  • RCKT N/A
  • OIS 2001
  • Fundamental
  • Price
  • RCKT $3.19
  • OIS $5.75
  • Analyst Decision
  • RCKT Buy
  • OIS Buy
  • Analyst Count
  • RCKT 13
  • OIS 2
  • Target Price
  • RCKT $12.96
  • OIS $7.25
  • AVG Volume (30 Days)
  • RCKT 5.7M
  • OIS 466.3K
  • Earning Date
  • RCKT 11-06-2025
  • OIS 10-29-2025
  • Dividend Yield
  • RCKT N/A
  • OIS N/A
  • EPS Growth
  • RCKT N/A
  • OIS N/A
  • EPS
  • RCKT N/A
  • OIS 0.11
  • Revenue
  • RCKT N/A
  • OIS $664,287,000.00
  • Revenue This Year
  • RCKT N/A
  • OIS N/A
  • Revenue Next Year
  • RCKT $108.43
  • OIS $5.23
  • P/E Ratio
  • RCKT N/A
  • OIS $52.37
  • Revenue Growth
  • RCKT N/A
  • OIS N/A
  • 52 Week Low
  • RCKT $2.19
  • OIS $3.08
  • 52 Week High
  • RCKT $22.01
  • OIS $5.99
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 47.80
  • OIS 54.52
  • Support Level
  • RCKT $3.09
  • OIS $5.49
  • Resistance Level
  • RCKT $3.29
  • OIS $5.76
  • Average True Range (ATR)
  • RCKT 0.16
  • OIS 0.15
  • MACD
  • RCKT -0.02
  • OIS -0.29
  • Stochastic Oscillator
  • RCKT 14.64
  • OIS 99.57

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About OIS Oil States International Inc.

Oil States International Inc is a provider of manufactured products and services to the energy, industrial and military sectors. Manufactured products include engineered capital equipment as well as products consumed in the drilling, well construction and production of oil and natural gas. The company sells its products and services to national oil and natural gas companies, oil and natural gas companies, onshore and offshore drilling companies and other oilfield services, defense and industrial companies. The company operates through three business segments, Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. It gains maximum revenue from Offshore Manufactured Products.

Share on Social Networks: